Woodbrook Group Holdings Inc. (OTCPK: WDBG)
Health Care · Pharmaceuticals · CY
$—
— today · — 1Y
Woodbrook Group Holdings Inc. (OTCPK: WDBG) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $165.64M and employs 30 people.
trading between 0.00 and 0.75.
Tweenvest scores Woodbrook Group Holdings Inc. across four factors: value 0/100. Its strongest factor is value.
WDBG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $165.64M
- Revenue (TTM)
- $4.92M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- -370.67
- 52-week high
- $0.75
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 331.27M
- Employees
- 30
- Next earnings
- —
About Woodbrook Group Holdings Inc.
Woodbrook Group Holdings, Inc. provides investment and strategic planning advisory services. The company was founded in 1996 and is headquartered in Henderson, NV.
- ISIN
- US9788872060
- Listed since
- Feb 2, 2006
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.